COMPLEMENT--PLASMA MEMBRANE FUNCTIONAL INTERACTIONS
补体--质膜功能相互作用
基本信息
- 批准号:6330018
- 负责人:
- 金额:$ 34.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-07-01 至 2002-11-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction cell membrane chemotaxis complement complement pathway complement receptor erythrocyte membrane human subject immunomodulators inflammation laboratory mouse laboratory rabbit membrane permeability membrane structure monoclonal antibody neutrophil phlebotomy protein structure receptor binding receptor expression superoxides
项目摘要
Complement is a circulating system composed of many different
proteins which is known for its ability to lyse animal cells and
bacteria. This application seeks support for a series of
investigations on the effects of complement on that do not lead to
lysis of the target cell: the sublytic events. This proposal
stems from our observation that when complement is activated at
sublytical concentrations, influx of Na and L-glucose into the
unlysed erthrocytes increases dramatically, albeit transiently, and
yet the affected cells do not lyse or swell, as would be expected.
We found that this non-lethal permeability increase is produced by
the membrane attack complex, which is a macromolecular complex of
the terminal complement components. Further we determined that C8,
but not C9, is necessary to produce the sublytic change in
permeability and that in response to the sublytic complement
attack, there is activation of a Ca-dependent K permeability
pathway. This promotes net K efflux and prevents the
colloidosmotic swelling and lysis that occurs when the membrane
damage is permanent and permits the survival of the affected cell.
In PNH, a disease characterized by a dramatic increase in the
sensitivity of erythrocytes to complement lysis, there is
apparently a lack of sublytic changes for reasons not yet
completely understood. Our specific aims include: 1) continue our
studies on the complement regulatory proteins DAF and C8bp,
particularly in relation to their role in the sublytic events; 2)
characterize further the transient permeability changes and the
volume regulatory transport mechanism through studies on ion fluxes
during exposure to sublytic complement; and 3) determine the
biological consequences of the sublytic events to the cells that
survive a complement attack. We will perform studies in normal and
PNH erthrocytes, as well as in cells carrying abnormal hemoglobin,
such as SS, SC, or CC which are known to have volume regulatory
pathways that we predict would decrease their sensitivity to
complement lysis. We expect that our investigations will help
better understanding complement mediated diseases, such as lupus
erythematous and immune hemolytic anemia, and also provide
important information on the physiological functions of the
complement system and its regulatory proteins.
补体是一个循环系统,由许多不同的
蛋白质,以其裂解动物细胞和
细菌。此应用程序寻求对一系列
补体对非致病因素影响的研究
靶细胞的裂解:亚裂解事件。这项建议
源于我们的观察,当补体在
亚细胞浓度,钠和L-葡萄糖进入细胞内
未裂解的红细胞急剧增加,尽管是暂时的,而且
然而,受影响的细胞并不像预期的那样溶解或肿胀。
我们发现,这种非致命性的渗透率增加是由
膜攻击复合体,它是一种大分子复合体
终端补充部件。进一步我们确定C8,
而不是C9,是产生亚溶质变化所必需的
渗透性和对亚溶质补体的反应
发作时,钙依赖的钾通透性被激活
路径。这会促进净K外流,并防止
胶体渗透性肿胀和溶解时发生的膜
损伤是永久性的,并允许受影响的细胞存活。
在PNH中,一种疾病的特征是
红细胞对补体溶解的敏感性,有
显然,由于目前还没有的原因,缺乏亚分辨率的改变
完全理解。我们的具体目标包括:1)继续我们的
补体调节蛋白DAF和C8BP的研究
特别是与它们在次要事件中的作用有关;2)
进一步表征了瞬时渗透率的变化和
离子通量研究中的体积调节输运机制
在接触亚溶血补体的过程中;以及3)确定
亚致死事件对细胞的生物学影响
在补给攻击中幸存下来。我们将在正常和
PNH红细胞,以及携带异常血红蛋白的细胞,
例如已知具有音量调节SS、SC或CC
我们预测的通路会降低它们对
补体溶解。我们希望我们的调查能有所帮助。
更好地了解补体介导的疾病,如狼疮
红斑性和免疫性溶血性贫血,还提供
有关细胞生理功能的重要信息
补体系统及其调节蛋白。
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9).
- DOI:10.1182/blood.v81.1.200.bloodjournal811200
- 发表时间:1993
- 期刊:
- 影响因子:20.3
- 作者:J. Halperin;A. Taratuska;M. Rynkiewicz;A. Nicholson‐Weller
- 通讯作者:J. Halperin;A. Taratuska;M. Rynkiewicz;A. Nicholson‐Weller
Paramyosin inhibits complement C1.
- DOI:10.4049/jimmunol.148.1.124
- 发表时间:1992-01
- 期刊:
- 影响因子:4.4
- 作者:J. Laclette;Charles B. Shoemaker;D. Richter;L. Arcos;Nelly Panté;C. Cohen;D. Bing;A. Nicholson‐Weller
- 通讯作者:J. Laclette;Charles B. Shoemaker;D. Richter;L. Arcos;Nelly Panté;C. Cohen;D. Bing;A. Nicholson‐Weller
Mechanisms by which the erythrocyte protects itself from complement damage.
红细胞保护自身免受补体损伤的机制。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Nicholson-Weller,A;Halperin,JA
- 通讯作者:Halperin,JA
Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.
阵发性睡眠性血红蛋白尿。
- DOI:10.1159/000463072
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Halperin,JA;Nicholson-Weller,A
- 通讯作者:Nicholson-Weller,A
Decay accelerating factor (CD55).
- DOI:10.1007/978-3-642-77014-2_2
- 发表时间:1992
- 期刊:
- 影响因子:0
- 作者:A. Nicholson‐Weller
- 通讯作者:A. Nicholson‐Weller
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE NICHOLSON-WELLER其他文献
ANNE NICHOLSON-WELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE NICHOLSON-WELLER', 18)}}的其他基金
CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
CR1 (CD35) 作为 CIQ 的细胞受体
- 批准号:
2887721 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CRI (CD35) As a Cellular Receptor for CIq
CRI (CD35) 作为 CIq 的细胞受体
- 批准号:
6711776 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
CR1 (CD35) 作为 CIQ 的细胞受体
- 批准号:
6170691 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
CR1 (CD35) 作为 CIQ 的细胞受体
- 批准号:
6373824 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
CR1 (CD35) 作为 CIQ 的细胞受体
- 批准号:
2607884 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CRI (CD35) As a Cellular Receptor for CIq
CRI (CD35) 作为 CIq 的细胞受体
- 批准号:
6866409 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CRI (CD35) As a Cellular Receptor for CIq
CRI (CD35) 作为 CIq 的细胞受体
- 批准号:
7191597 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CRI (CD35) As a Cellular Receptor for CIq
CRI (CD35) 作为 CIq 的细胞受体
- 批准号:
7019994 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
CRI (CD35) As a Cellular Receptor for CIq
CRI (CD35) 作为 CIq 的细胞受体
- 批准号:
6630106 - 财政年份:1998
- 资助金额:
$ 34.97万 - 项目类别:
COMPLEMENT--PLASMA MEMBRANE FUNCTIONAL INTERACTIONS
补体--质膜功能相互作用
- 批准号:
2028181 - 财政年份:1989
- 资助金额:
$ 34.97万 - 项目类别:
相似海外基金
Discovery of cell membrane permeable HDAC6 PROTACs
细胞膜渗透性 HDAC6 PROTAC 的发现
- 批准号:
23K06061 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Control of cell membrane permeability by intense electrical pulses and development of innovative food processing
通过强电脉冲控制细胞膜渗透性和创新食品加工的发展
- 批准号:
23H01403 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a method to inhibit epithelial-mesenchymal transition by targeting cell membrane phospholipids
开发一种通过靶向细胞膜磷脂抑制上皮间质转化的方法
- 批准号:
23K06103 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
使用创新的 MOD 技术发现针对细胞膜结合靶蛋白的高通量抗体,用于单细胞测定中的直接筛选
- 批准号:
10698891 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Three-dimensional measurement of cell-sercreted molecules using probe-type artificial cell membrane systems
使用探针型人工细胞膜系统对细胞分泌分子进行三维测量
- 批准号:
23H01822 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
- 批准号:
10667060 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Nanostructure transfer to cell membrane by cytoplasmic gelation and its optical sensor application
细胞质凝胶化纳米结构转移至细胞膜及其光学传感器应用
- 批准号:
22K18760 - 财政年份:2022
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
An extedned research of cell membrane domains based on the probes of membrane molecules
基于膜分子探针的细胞膜域扩展研究
- 批准号:
22H00359 - 财政年份:2022
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (A)














{{item.name}}会员




